Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Nutritional Management of Sarcopenia in Patients With Heart Failure

Authors not listed

Maimónides Biomedical Research Institute of Córdoba · 2024

Abstract

Sarcopenia is a frequent complication in patients with cancer and chronic diseases, it is characterized by decreased muscle strength and fatigue due to reduced skeletal muscle mass, which is accompanied by atrophy and decreased quality of muscle tissue. In all cases, it negatively impacts treatment tolerance, clinical outcomes and survival, in consequence, quality of life of these patients decreases while morbidity, mortality and costs increase. In this context, appropriate nutritional screening and early nutrition support are extremely recommended, to this aim, in some cases, oral nutritional supplements (ONS) are necessary; ONS could have a standard formula or be enriched with specific nutrients. There is a lack of evidence for supporting its use or the use of protein modules in other clinical conditions including patients with heart failure

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-28 MST

Cite this

APA
Anonymous. (2024). Nutritional Management of Sarcopenia in Patients With Heart Failure. <em>Maimónides Biomedical Research Institute of Córdoba</em>. https://clinicaltrials.gov/study/NCT06634316
Vancouver
Anonymous. Nutritional Management of Sarcopenia in Patients With Heart Failure. Maimónides Biomedical Research Institute of Córdoba. 2024.
BibTeX
@misc{anon2024Nutrit, title = {Nutritional Management of Sarcopenia in Patients With Heart Failure}, author = {Anonymous}, journal = {Maimónides Biomedical Research Institute of Córdoba}, year = {2024}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings